Azole susceptibility of Malassezia pachydermatis and Malassezia furfur and tentative epidemiological cut-off values.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Medical Mycology

• Publication date

  2015-09-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1093/mmy/myv049PMID 26162472
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vitro antifungal susceptibility of Malassezia furfur from bloodstream infections.

  2014cited by this paper
• Bloodstream infections by Malassezia and Candida species in critical care patients.

  2014cited by this paper
• European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) and European Confederation of Medical Mycology (ECMM) 2013 joint guidelines on diagnosis and management of rare and emerging fungal diseases.

  2014cited by this paper
• ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections.

  2014cited by this paper
• Multilaboratory Study of Epidemiological Cutoff Values for Detection of Resistance in Eight Candida Species to Fluconazole, Posaconazole, and Voriconazole

  2014cited by this paper
• Antifungal agent susceptibilities and interpretation of Malassezia pachydermatis and Candida parapsilosis isolated from dogs with and without seborrheic dermatitis skin.

  2013cited by this paper
• In vitro antifungal activity of topical and systemic antifungal drugs against Malassezia species

  2013cited by this paper
• Human Skin Fungal Diversity

  2013cited by this paper
• Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole for Six Candida Species as Determined by the Colorimetric Sensititre YeastOne Method

  2013cited by this paper
• Population-Based Survey of Filamentous Fungi and Antifungal Resistance in Spain (FILPOP Study)

  2013cited by this paper
• Fluconazole-resistant Candida: collateral damage associated with prior antibacterial exposure?

  2012cited by this paper
• Antibiotic Exposure as a Risk Factor for Fluconazole-Resistant Candida Bloodstream Infection

  2012cited by this paper
• The Malassezia Genus in Skin and Systemic Diseases

  2012cited by this paper
• Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012

  2012cited by this paper
• ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.

  2012cited by this paper
• Assessment of the antifungal susceptibility of Malassezia pachydermatis in various media using a CLSI protocol.

  2012influential reference
• Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment.

  2012cited by this paper
• Influence of doxorubicin on fluconazole susceptibility and efflux pump gene expression of Candida dubliniensis.

  2012cited by this paper
• Malassezia furfur fungaemia in a neonatal patient detected by lysis‐centrifugation blood culture method: first case reported in Italy

  2011cited by this paper
• Advances in the identification of Malassezia.

  2011cited by this paper
• Triazole and Echinocandin MIC Distributions with Epidemiological Cutoff Values for Differentiation of Wild-Type Strains from Non-Wild-Type Strains of Six Uncommon Species of Candida

  2011influential reference
• An azole-resistant isolate of Malassezia pachydermatis.

  2011cited by this paper
• In vitro susceptibility of fluconazole-susceptible and -resistant isolates of Malassezia pachydermatis against azoles.

  2011cited by this paper
• Superficial veterinary mycoses.

  2010cited by this paper
• In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms.

  2009cited by this paper
• Evidence-based veterinary dermatology: a systematic review of interventions for Malassezia dermatitis in dogs.

  2009cited by this paper
• Tetracycline alters drug susceptibility in Candida albicans and other pathogenic fungi.

  2008cited by this paper
• Epidemiological Cutoffs and Cross-Resistance to Azole Drugs in Aspergillus fumigatus

  2008cited by this paper
• Update on the genus Malassezia.

  2007cited by this paper
• Antifungal activities of azole agents against the Malassezia species.

  2007cited by this paper
• A Modified Christensen's Urea and CLSI Broth Microdilution Method for Testing Susceptibilities of Six Malassezia Species to Voriconazole, Itraconazole, and Ketoconazole

  2006cited by this paper
• The prevention of febrile neutropenia

  2006cited by this paper
• Use of Fatty Acid RPMI 1640 Media for Testing Susceptibilities of Eight Malassezia Species to the New Triazole Posaconazole and to Six Established Antifungal Agents by a Modified NCCLS M27-A2 Microdilution Method and Etest

  2005cited by this paper
• Environmental surveillance and other control measures in the prevention of nosocomial fungal infections.

  2001cited by this paper
• Guidelines for the management of intravascular catheter-related infections.

  2001cited by this paper
• Guidelines for the management of intravascular catheter-related infections.

  2001cited by this paper
• In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine

  2000cited by this paper
• Identification of Malassezia species : A practical approach

  1996cited by this paper
• Infectious Diseases Society of America

  1969cited by this paper

• Invasive Infections Caused by Malassezia spp: A Comprehensive Review of Cases from 1979 to 2024.

  2026cites this paper
• Cinnamomum burmannii Essential Oil as a Promising Antimicrobial Agent Against Cutaneous Pathogens: Mechanistic Insights into Its Anti-Malassezia furfur Activity

  2025cites this paper
• Antifungal Susceptibility of Malassezia pachydermatis Isolates from Companion Animals and Genomic Insights into Resistance Mechanisms

  2025cites this paper
• Comparison of the in vitro antibiofilm activities of otic cleansers against canine otitis externa pathogens

  2025cites this paper
• Extracellular phospholipase production by Malassezia pachydermatis strains and its inhibition by selected antimycotics and plant essential oil components

  2024influential citation
• Action of mycocins produced by Wickerhamomyces anomalus on Malassezia pachydermatis isolated from the ear canal of dogs.

  2024cites this paper
• Prevalence and genetic diversity of azole-resistant Malassezia pachydermatis isolates from canine otitis and dermatitis: a two-year study.

  2024cites this paper
• Clinical safety and efficacy of a single-dose gentamicin, posaconazole and mometasone furoate otic suspension for treatment of canine otitis externa.

  2024cites this paper
• Malassezia dermatitis in dogs and cats.

  2024cites this paper
• Analysis of the culturable gut yeast microbiota of dogs with digestive disorders.

  2024cites this paper
• Possible plant-based solutions for skin yeast infections

  2024cites this paper
• Comparative analysis of the distribution and antifungal susceptibility of yeast species in cat facial hair and human nails

  2024cites this paper
• In vitro sensitivity of Malassezia furfur isolates from HIV-positive and negative patients to antifungal agents

  2023cites this paper
• Antibiotic Susceptibility Testing and Establishment of Tentative Species-Specific Microbiological Cut-off Values for Bifidobacteria Isolated from Chinese Population

  2023cites this paper
• Potential role of broad-spectrum azoles as therapy for Malasezzia bloodstream infection

  2023cites this paper
• Comparison of virulence factors and susceptibility profiles of Malassezia furfur from pityriasis versicolor patients and bloodstream infections of preterm infants.

  2023cites this paper
• Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and animal skin

  2023cites this paper
• In vitro effects of omeprazole in combination with antifungal compounds against Malassezia pachydermatis

  2023cites this paper
• Malassezia: Zoonotic Implications, Parallels and Differences in Colonization and Disease in Humans and Animals

  2022influential citation
• Malassezia species: the need to establish Epidemiological Cutoff Values.

  2022cites this paper
• Difficulties in diagnosing Malassezia furfur bloodstream infection and possibility of spontaneous resolution in a patient undergoing chemotherapy for neuroblastoma: A case report.

  2022cites this paper
• Augmenting Azoles with Drug Synergy to Expand the Antifungal Toolbox

  2022cites this paper
• In Vitro Biofilm Formation by Malassezia pachydermatis Isolates and Its Susceptibility to Azole Antifungals

  2022cites this paper
• Herbal Therapy for the Treatment of Seborrhea Dermatitis

  2022cites this paper
• In Vitro Assessment of Azole and Amphotericin B Susceptibilities of Malassezia spp. Isolated from Healthy and Lesioned Skin

  2022cites this paper
• Many ways, one microorganism: Several approaches to study Malassezia in interactions with model hosts

  2022cites this paper
• Virulence factors of Malassezia strains isolated from pityriasis versicolor patients and healthy individuals.

  2022cites this paper
• Antifungal Resistance among Less Prevalent Candida Non-albicans and Other Yeasts versus Established and under Development Agents: A Literature Review

  2021cites this paper
• Evaluation of Tetracycline Resistance and Determination of the Tentative Microbiological Cutoff Values in Lactic Acid Bacterial Species

  2021cites this paper
• Antifungal Effect of Antimicrobial Photodynamic Therapy Mediated by Haematoporphyrin Monomethyl Ether and Aloe Emodin on Malassezia furfur

  2021cites this paper
• Antifungal Resistance in Animal Medicine: Current State and Future Challenges

  2021cites this paper
• Azole Resistance Mechanisms in Pathogenic Malassezia furfur

  2021cites this paper
• Antifungal Activity of the Essential Oils of Osteophloeum platyspermum (Myristicaceae) against Malassezia spp. and Candida albicans Influenced by Seasonality and Climatic Factors

  2021cites this paper
• Malassezia spp. Yeasts of Emerging Concern in Fungemia

  2020influential citation
• Biology, diagnosis and treatment of Malassezia dermatitis in dogs and cats Clinical Consensus Guidelines of the World Association for Veterinary Dermatology.

  2020cites this paper
• Effect of chlorogenic and gallic acids combined with azoles on antifungal susceptibility and virulence of multidrug-resistant Candida spp. and Malassezia furfur isolates.

  2020cites this paper
• Uncommon Yeasts and Molds Causing Human Disease

  2020cites this paper
• Genomic Multiplication and Drug Efflux Influence Ketoconazole Resistance in Malassezia restricta

  2020cites this paper
• Use of whole-genome sequencing to detect an outbreak of Malassezia pachydermatis infection and colonization in a neonatal intensive care unit—California, 2015–2016

  2020cites this paper
• In Vitro Azole and Amphotericin B Susceptibilities of Malassezia furfur from Bloodstream Infections Using E-Test and CLSI Broth Microdilution Methods

  2020cites this paper
• Antifungal Resistance Regarding Malassezia pachydermatis: Where Are We Now?

  2020cites this paper
• Conventional therapy and new antifungal drugs against Malassezia infections.

  2020cites this paper
• In vitro activity of carvacrol, cinnamaldehyde and thymol combined with antifungals against Malassezia pachydermatis.

  2019cites this paper
• Epidemiology and susceptibility profile to classic antifungals and over-the-counter products of Malassezia clinical isolates from a Portuguese University Hospital: a prospective study.

  2019cites this paper
• Carbonic anhydrases from pathogens

  2019cites this paper
• Susceptibility of Malassezia pachydermatis Clinical Isolates to Allopathic Antifungals and Brazilian Red, Green, and Brown Propolis Extracts

  2019cites this paper
• Antifungal activity of different essential oils against Malassezia pathogenic species.

  2019cites this paper
• Development of advanced antimicrobial combinations for the treatment of canine otitis externa

  2018influential citation
• Blood culture procedures and diagnosis of Malassezia furfur bloodstream infections: Strength and weakness

  2018cites this paper
• Treatment of Selected Canine Dermatological Conditions in Portugal – A Research Survey

  2018cites this paper
• In vitro antimicrobial activity of seven adjuvants against common pathogens associated with canine otitis externa

  2018cites this paper
• Malassezia infections with systemic involvement: Figures and facts

  2018cites this paper
• Oxythiamine improves antifungal activity of ketoconazole evaluated in canine Malassezia pachydermatis strains

  2018cites this paper
• An experimental murine model of otitis and dermatitis caused by Malassezia pachydermatis

  2018cites this paper
• In vitro antimicrobial activity of monensin against common clinical isolates associated with canine otitis externa.

  2018cites this paper
• In vitro combination of antifungal agents against Malassezia pachydermatis

  2018cites this paper
• Malassezia pachydermatis from animals: Planktonic and biofilm antifungal susceptibility and its virulence arsenal.

  2018cites this paper
• Antifungal Use in Veterinary Practice and Emergence of Resistance

  2018cites this paper
• In vitro antimicrobial activity of narasin against common clinical isolates associated with canine otitis externa

  2018cites this paper
• Malassezia ecology, pathophysiology, and treatment.

  2018cites this paper
• Dittrichia viscosa L. leaves lipid extract: An unexploited source of essential fatty acids and tocopherols with antifungal and anti-inflammatory properties

  2018cites this paper
• Pityriasis Versicolor: Treatment Update

  2018cites this paper
• Methodological Issues in Antifungal Susceptibility Testing of Malassezia pachydermatis

  2017cites this paper
• The role of drug efflux pumps in Malassezia pachydermatis and Malassezia furfur defence against azoles

  2017cites this paper
• Targeting Malassezia species for Novel Synthetic and Natural Antidandruff Agents.

  2017cites this paper
• Minimal inhibitory concentration distributions and epidemiological cutoff values of five antifungal agents against Sporothrix brasiliensis

  2017cites this paper
• Rare Yeast Infections: Risk Factors, Clinical Manifestations, Treatment, and Special Considerations

  2017cites this paper
• Evaluation of the in vitro expression of ATP binding-cassette (ABC) proteins in an Ixodes ricinus cell line exposed to ivermectin

  2016cites this paper
• Use of a modified hair strand test to assess the antifungal activity kinetics of dog hair after a 2% climbazole shampoo application.

  2016cites this paper
• Malassezia pachydermatis keratomycosis in a dog

  2015cites this paper